BusinessAXIM® Biotechnologies, Inc. Secures Funding to Continue Pharmaceutical Clinical Trials Program in Cannabinoid Research and Development for Multiple IndicationsBy Nasdaq OMXOct 26, 2016, 1:04 PM UTC
BusinessIGC Files International Applications for Cannabinoid Composition and Method PatentsBy Nasdaq OMXMar 15, 2016, 12:30 PM UTC
BusinessIGC Expands Infrastructure Development Capabilities with AcquisitionBy Nasdaq OMXFeb 16, 2016, 1:00 PM UTC
